1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

20 Mar 2024
Admin
News Article

Roquette Soon to Acquire IFF Pharma Solutions

Roquette to acquire New York-based excipients producer, IFF Pharma Solutions

Overview

Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, announced an agreement to acquire IFF Pharma Solutions, a worldwide producer of excipients for oral dosage solutions, to reinforce its position as a major partner to the pharmaceutical industry.

Impacts of Acquisition

The combination of the two complementary businesses will rebalance the company’s portfolio around the two pillars of health and nutrition. It will expand its pharma product range and significantly accelerate Roquette’s growth.

About IFF

IFF is headquartered in New York (USA).
Its pharmaceutical division is a world-class producer of excipients for oral dosage solutions, with revenues of approximately $1 billion, 10 research and development and/or production sites globally, and around 1,100 employees.
It has an extensive range of high-quality products, established brands and a client base of major pharmaceutical, food and nutraceutical companies around the world.

A Revolutionary Strategic Step

The acquisition of IFF Pharma Solutions is a transformative strategic step for Roquette.
It expands its position in the attractive excipients market which benefits from strong fundamentals and outstanding growth prospects.
It enhances Roquette’s US footprint, and it significantly expands its industry-leading formulation capabilities and drug delivery research and development.
It turns the company into the pharmaceutical industry’s partner of choice for the development of innovative drug delivery solutions to best address current and future customer needs, and to improve patients’ lives.
Roquette and IFF target to close the transaction in the first half of 2025. Closing remains subject to regulatory clearance and satisfaction of other customary closing conditions.

Words from CEO: Roquette

Pierre Courduroux, Roquette CEO, said: “After last year’s acquisition of Qualicaps, today’s announcement is a decisive step in our journey to reinforce our position in the health and nutrition markets. The combination of our excipients’ expertise with IFF Pharma Solutions is a fantastic opportunity to become a true global specialist in drug delivery and oral dosage solutions. This responds to the needs of customers and patients looking for continuously better treatments. We very much look forward to welcoming IFF Pharma Solutions, and to jointly building the next chapter of our company’s growth history.”

Words from CEO: IFF

Erik Fyrwald, IFF CEO, added: “We are pleased to reach an agreement with Roquette that will support Pharma Solutions’ next chapter of growth as a trusted partner for the pharmaceutical industry. This represents a great opportunity for our team and customers. Roquette is the ideal strategic partner for IFF Pharma Solutions, with whom it has complementary portfolio and innovation capabilities, and with whom it shares a culture of operational excellence.

About Roquette

Roquette is a family-owned global leader in plant-based ingredients and a leading provider of pharmaceutical excipients. Founded in 1933, the company currently operates in more than 100 countries, through more than 30 manufacturing sites.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!